MoneyWorks4Me

Sanjivani Paranteral - Quaterly Results

27 May 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 181.81 millions rose by 41.33% from Rs. 128.64 millions.Handsome Net Profit growth of 74.32% reported above the corresponding previous quarter figure of Rs. 21.93 millions to Rs. 12.58 millions.OP of the company witnessed a marginal growth to 30.47 millions from 22.11 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 181.81 128.64 41.33 700.99 544.10 28.83 700.99 544.10 28.83
Other Income 4.27 0.52 721.15 12.14 5.17 134.82 12.14 5.17 134.82
PBIDT 30.47 22.11 37.81 115.73 87.58 32.14 115.73 87.58 32.14
Interest 2.02 0.88 129.55 5.93 2.54 133.46 5.93 2.54 133.46
PBDT 28.45 21.23 34.01 109.80 85.04 29.12 109.80 85.04 29.12
Depreciation 1.84 2.38 -22.69 6.21 9.33 -33.44 6.21 9.33 -33.44
PBT 26.61 18.85 41.17 103.59 75.71 36.82 103.59 75.71 36.82
TAX 4.68 6.27 -25.36 22.58 14.07 60.48 22.58 14.07 60.48
Deferred Tax 4.13 0.48 760.42 4.13 0.48 760.42 4.13 0.48 760.42
PAT 21.93 12.58 74.32 81.01 61.64 31.42 81.01 61.64 31.42
Equity 118.82 116.84 1.69 118.82 116.84 1.69 118.82 116.84 1.69
PBIDTM(%) 16.76 17.19 -2.49 16.51 16.10 2.57 16.51 16.10 2.57
Peers
Company Name CMP
Sun Pharma. Inds. 1849.10
Dr. Reddys Labs. 1201.00
Cipla 1406.25
Lupin 2085.80
Zydus Lifesciences 1198.00
View more..